Advanced human immunodeficiency virus disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis
Clinical Infectious Diseases Aug 30, 2017
Tenforde MW, et al. – A nationwide surveillance study was undertaken to determine the national incidence of cryptococcal meningitis (CM), and describe characteristics of cases during 2000Â2014 and temporal trends at 2 national referral hospitals. Despite its well–developed antiretroviral therapy (ART) program, Botswana indicated a substantial burden of advanced HIV, with 2013Â2014 incidence of CM comparable to pre–ART era rates in South Africa. Findings thereby suggested that a key population of individuals, often men, had been developing advanced disease and associated opportunistic infections due to a failure to effectively engage in care, highlighting the need for differentiated care models.
Methods
- Authors collected cerebrospinal fluid data from all 37 laboratories performing meningitis diagnostics in Botswana from the period 2000Â2014 to identify cases of CM.
- Record of basic demographic and laboratory data was maintained.
- They used complete national data from 2013Â2014 to calculate national incidence using UNAIDS population estimates.
- Derivation of temporal trends in cases was performed from national referral centers in the period 2004Â2014.
Results
- In 4702 individuals, 5296 episodes of CM were identified; 60.6% were male, and median age was 36 years.
- In this study, overall 2013Â2014 incidence was 17.8 (95% confidence interval [CI], 16.6Â19.2) cases per 100000 person-years.
- Incidence was 96.8 (95% CI, 90.0Â104.0) cases per 100000 person-years in the HIV-infected population; there appeared male predominance across CD4 strata.
- At national referral hospitals, during 2007Â2009, cases decreased but cases stabilized during 2010Â2014.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries